NO20074768L - Anvendelse av pyrazolderivater for fremstilling av medisiner nyttige for a forebygge eller behandle nyresykdommer - Google Patents

Anvendelse av pyrazolderivater for fremstilling av medisiner nyttige for a forebygge eller behandle nyresykdommer

Info

Publication number
NO20074768L
NO20074768L NO20074768A NO20074768A NO20074768L NO 20074768 L NO20074768 L NO 20074768L NO 20074768 A NO20074768 A NO 20074768A NO 20074768 A NO20074768 A NO 20074768A NO 20074768 L NO20074768 L NO 20074768L
Authority
NO
Norway
Prior art keywords
kidney disease
preventing
preparation
pyrazole derivatives
treating kidney
Prior art date
Application number
NO20074768A
Other languages
English (en)
Inventor
Jean-Marc Herbert
Philip Janiak
Mohammed Bensaid
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0501919A external-priority patent/FR2882262B1/fr
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20074768L publication Critical patent/NO20074768L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører anvendelsen av en cannabinold CB 1 reseptor antagonist forbindelse, alene eller kombinert med en annen aktiv ingrediens, avledet fra pyrazol, for å fremstille legemidler nyttige i forbebygging og behandling av nyresykdommer.
NO20074768A 2005-02-23 2007-09-18 Anvendelse av pyrazolderivater for fremstilling av medisiner nyttige for a forebygge eller behandle nyresykdommer NO20074768L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0501919A FR2882262B1 (fr) 2005-02-23 2005-02-23 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
FR0504798A FR2882263B1 (fr) 2005-02-23 2005-05-12 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
PCT/FR2006/000369 WO2006090047A1 (fr) 2005-02-23 2006-02-17 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales

Publications (1)

Publication Number Publication Date
NO20074768L true NO20074768L (no) 2007-11-23

Family

ID=36603585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074768A NO20074768L (no) 2005-02-23 2007-09-18 Anvendelse av pyrazolderivater for fremstilling av medisiner nyttige for a forebygge eller behandle nyresykdommer

Country Status (18)

Country Link
US (1) US7622488B2 (no)
EP (1) EP1855675A1 (no)
JP (1) JP2008531526A (no)
KR (1) KR20070104916A (no)
AR (1) AR054003A1 (no)
AU (1) AU2006217794A1 (no)
BR (1) BRPI0607894A2 (no)
CA (1) CA2597802A1 (no)
CR (1) CR9270A (no)
EA (1) EA011655B1 (no)
FR (1) FR2882263B1 (no)
IL (1) IL185165A0 (no)
MA (1) MA29263B1 (no)
MX (1) MX2007009995A (no)
NO (1) NO20074768L (no)
TN (1) TNSN07291A1 (no)
TW (1) TW200640458A (no)
WO (1) WO2006090047A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
FR2958850B1 (fr) * 2010-04-14 2012-07-06 Centre Nat Rech Scient Medicaments pour la prevention ou le traitement des addictions aux drogues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
US20040122033A1 (en) * 2002-12-10 2004-06-24 Nargund Ravi P. Combination therapy for the treatment of obesity
US20040214804A1 (en) * 2003-04-25 2004-10-28 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-obesity agent
AR051446A1 (es) * 2004-09-23 2007-01-17 Bristol Myers Squibb Co Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)

Also Published As

Publication number Publication date
WO2006090047A1 (fr) 2006-08-31
TNSN07291A1 (en) 2008-12-31
EA011655B1 (ru) 2009-04-28
AR054003A1 (es) 2007-05-30
EP1855675A1 (fr) 2007-11-21
CA2597802A1 (fr) 2006-08-31
MX2007009995A (es) 2007-10-10
EA200701800A1 (ru) 2008-02-28
US7622488B2 (en) 2009-11-24
FR2882263B1 (fr) 2007-04-06
CR9270A (es) 2007-10-01
FR2882263A1 (fr) 2006-08-25
IL185165A0 (en) 2008-06-05
AU2006217794A1 (en) 2006-08-31
US20080015228A1 (en) 2008-01-17
TW200640458A (en) 2006-12-01
JP2008531526A (ja) 2008-08-14
MA29263B1 (fr) 2008-02-01
BRPI0607894A2 (pt) 2009-10-20
KR20070104916A (ko) 2007-10-29

Similar Documents

Publication Publication Date Title
WO2006116148A3 (en) (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
NO20084489L (no) Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet
NO20054876L (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
WO2006067445A3 (en) Csf-1r kinase inhibitors
WO2005097125A3 (en) Methods and compositions for the treatment, prevention or management of diysfunctional sleep and dysfunctional sleep associated with disease
WO2005082893A3 (en) Histamine h3 receptor antagonists, preparation and therapeutic uses
NO20090321L (no) Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte
WO2005039485A3 (en) Gsk-3 inhibitors and uses thereof
WO2007113558A8 (en) Quinazolinone derivatives having b-raf inhibitory activity
ATE520668T1 (de) Sigmarezeptor-inhibitoren
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
MX2009004561A (es) Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
WO2007046867A3 (en) Piperidine derivatives and their uses as therapeutic agents
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
WO2007064448A3 (en) Cancer treatment using fts and 2-deoxyglucose
WO2008026156A3 (en) Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor
WO2007092469A3 (en) Combination of organic compounds
WO2006108682A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use as anti-fungal agents
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
MX2009007038A (es) Derivados de mononitrato de isosorbida para el tratamiento de trastornos intestinales.
WO2007006790A3 (en) Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist
WO2007009686A3 (en) Substituted pyrazoline compounds, their preparation and use as medicaments

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application